CVS

CVS HEALTH
D

CVS

Arincen56/100B
83.870
USD
2.53
(3.11%)
Post Trading·84.200USD+0.330(+0.39%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q3 FY2026 results
EPS2.09+26.7%Revenue108.40B+3.5%
OverviewFinancialsNewsForecastEarningsDividendsCompany

CVS HEALTH revenue 1985–2026

CVS HEALTH's revenue in Q3 FY2026, the three months to 30 September 2026, was 108.40B USD, up 5.4% on the same quarter a year before. CVS HEALTH's revenue over the last twelve months was 420.61B USD, up 6.7% on the twelve months before. In fiscal year 2025 it was 402.07B USD, up 7.8% on the year before.

Last updated 6 Nov 2026 · Next report 9 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 2026420.61B+6.73%59.84B11.05B
FY202531 Dec 2025402.07B+7.85%55.36B1.77B
FY202431 Dec 2024372.81B+4.20%51.40B4.61B
FY202331 Dec 2023357.78B+10.95%54.43B8.34B
FY202231 Dec 2022322.47B+10.39%54.50B4.31B
FY202131 Dec 2021292.11B+8.71%52.12B8.00B
FY202031 Dec 2020268.71B+4.65%49.05B7.18B
FY201931 Dec 2019256.78B+31.96%45.53B6.63B
FY201831 Dec 2018194.58B+5.30%31.54B-594.00M
FY201731 Dec 2017184.79B+4.08%28.53B6.62B
FY201631 Dec 2016177.55B+15.82%28.83B5.32B
FY201531 Dec 2015153.29B+9.99%26.53B5.24B
FY201431 Dec 2014139.37B+9.94%25.37B4.64B
FY201331 Dec 2013126.76B+2.96%23.78B4.59B
FY201231 Dec 2012123.12B+14.98%22.49B3.86B
FY201131 Dec 2011107.08B+11.80%20.56B3.46B
FY201031 Dec 201095.78B-2.48%20.22B3.43B
FY200931 Dec 200998.22B+12.28%20.36B3.70B
FY200831 Dec 200887.47B+14.60%18.29B3.21B
FY200731 Dec 200776.33B+74.18%16.11B2.64B
FY200631 Dec 200643.82B+18.41%11.74B1.37B
FY200531 Dec 200537.01B+20.96%9.69B1.22B
FY200431 Dec 200430.59B+15.07%8.03B918.80M
FY200331 Dec 200326.59B+9.95%6.86B847.30M
FY200231 Dec 200224.18B+8.72%6.07B716.60M
FY200131 Dec 200122.24B+10.72%5.69B413.20M
FY200031 Dec 200020.09B+10.99%5.36B746.00M
FY199931 Dec 199918.10B+18.49%4.86B635.10M
FY199831 Dec 199815.27B+11.08%4.13B384.50M
FY199731 Dec 199713.75B+16.21%3.72B88.80M
FY199631 Dec 199611.83B+21.18%3.36B208.20M
FY199531 Dec 19959.76B-13.49%2.90B-572.80M
FY199431 Dec 199411.29B+8.15%4.03B307.50M
FY199331 Dec 199310.44B+0.02%3.77B331.80M
FY199231 Dec 199210.43B+5.53%3.90B133.40M
FY199131 Dec 19919.89B+13.81%3.72B346.70M
FY199031 Dec 19908.69B+15.00%3.31B385.30M
FY198931 Dec 19897.55B+11.41%2.99B398.10M
FY198831 Dec 19886.78B+14.33%2.69B354.50M
FY198731 Dec 19875.93B+12.69%2.36B285.40M
FY198631 Dec 19865.26B+10.21%2.12B238.30M
FY198531 Dec 19854.77B—1.92B210.20M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

CVS HEALTH revenue growth by segment

Q3 FY2026 against Q3 FY2025

Pharmacy Revenue64.06B
+7.6%
Premiums34.57B
+2.5%
Front Store Revenue5.16B
-0.5%
Product and Service, Other1.04B
+1.2%

CVS HEALTH revenue by segment over time

Pharmacy Revenue Premiums Front Store Revenue Product and Service, Other Retail Pharmacy Intersegment Eliminations Pharmacy Services
Fiscal yearPharmacy RevenuePremiumsFront Store RevenueProduct and Service, OtherRetail PharmacyIntersegment EliminationsPharmacy Services
FY2025229.03B +8.9%134.75B +9.6%21.46B -0.3%3.93B -75.4%— — —
FY2024210.27B -5.9%122.90B +23.9%21.52B -4.2%15.97B +38.6%— — —
FY2023223.45B +8.9%99.19B +16.2%22.46B -1.4%11.52B +37.2%— — —
FY2022205.12B +11.1%85.33B +12.1%22.78B +6.9%8.40B -5.1%— — —
FY2021184.62B +7.8%76.13B +9.8%21.32B +8.4%8.85B +16.4%— — —
FY2020171.29B +3.2%69.36B +9.9%19.66B +1.2%7.60B +3.8%— — —
FY2019165.90B +0.6%63.12B +671.3%19.42B +1.9%7.32B — — —
FY2018164.85B 8.18B 19.06B — — — —
FY2017— — — — 79.40B -2.1%-25.23B 130.60B +8.9%
FY2016— — — — 81.10B +12.6%-23.54B 119.96B +19.5%

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about CVS HEALTH's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.